Software Engineer (Senior / Staff / Principal)
Software Engineer (Senior / Staff / Principal)
Genesis Therapeutics
Burlingame, CA
See who Genesis Therapeutics has hired for this role
You will
- Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows
- Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction
- Help scale our data infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs
- A deep thinker who reasons from first principles, balances attention to detail with architectural thinking, and has an investigational curiosity to find the root cause of a problem
- Comfortable working across all levels of the software stack, from front-end interfaces to backend features to managing infrastructure
- Experienced writing production code and driving projects to completion
- Interested in learning more about drug discovery and machine learning
- The opportunity to work on high impact tools and products that are immediately deployed to accelerate the discovery of new medicines
- Strong technical coworkers in AI, software, and chemistry, who all have a powerful mix of intellectual curiosity and humility. The team reads and discusses 1-2 machine learning or chemistry papers every week to stay on top of the field and inspire new ideas
- Competitive salary and equity. Medical, dental, and vision insurance, and a 401(k) program
Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022, with a $20M upfront payment and a $670M total deal size), and Genentech (signed in 2020).
We raised a $200M series B in August 2023, and have raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
Finding the best talent is our top priority at Genesis Therapeutics. If you are interested in potential partnership on recruitment, please reach out to recruiting@genesistherapeutics.ai.
-
Seniority level
Not Applicable -
Employment type
Full-time -
Job function
Engineering and Information Technology -
Industries
Transportation, Logistics, Supply Chain and Storage, Internet Publishing, and Internet Publishing
Referrals increase your chances of interviewing at Genesis Therapeutics by 2x
See who you knowGet notified about new Senior Software Engineer jobs in Burlingame, CA.
Sign in to create job alertSimilar jobs
People also viewed
-
Software Engineer, Web
Software Engineer, Web
-
Software Engineer (Front-End)
Software Engineer (Front-End)
-
Software Engineer, Frontend
Software Engineer, Frontend
-
Software Engineer - Apps
Software Engineer - Apps
-
Frontend Software Engineer - University Graduate 2025
Frontend Software Engineer - University Graduate 2025
-
Software Engineer (Fullstack)
Software Engineer (Fullstack)
-
Full Stack Software Engineer, AI
Full Stack Software Engineer, AI
-
Software Engineer, Machine Learning
Software Engineer, Machine Learning
-
Software Engineer, Full Stack
Software Engineer, Full Stack
Similar Searches
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More